THE FIRST Tdap BOOSTER VACCINE
FOR BOTH ADOLESCENTS AND ADULTS
|
 |
Learn how vaccination can help protect against pertussis
ADACEL vaccine has been designed specifically to protect adolescents and adults 11 through 64 years from tetanus, diphtheria, and pertussis. It is similar to DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed), a diphtheria, tetanus, and pertussis vaccine used to protect infants and young children.
In clinical studies, DAPTACEL vaccine has been shown to provide1:
- 85% efficacy against severe pertussis (cough lasting 21 days or longer)
- 78% efficacy against all severities of pertussis
In addition to pertussis, ADACEL vaccine helps protect against two other serious diseases—tetanus and diphtheria. Ask your doctor if ADACEL vaccine is right for you and your family.
Reference: 1. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-355.
SAFETY INFORMATION
Indication
Adacel vaccine is given as a single dose to people 11 through 64 years of age for active booster immunization for the prevention of tetanus (lockjaw), diphtheria, and pertussis (whooping cough).
Safety Information
Side effects to Adacel vaccine include injection site pain, redness, and swelling; headache, body ache, tiredness, and fever. Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Other side effects may occur. Vaccination with Adacel vaccine may not protect all people receiving the vaccine.
For more information about Adacel vaccine, talk to your health-care professional.
Last modified: 2/20/09
